This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

PTC Therapeutics Inc (PTCT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 49.75M 15.41M 2.73M
Receivables 4.44M 957.72K 1.01M
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 323.57M 145.02M 4.60M
Property, Plant & Equipment, Gross 34.08M 29.41M 28.57M
Accumulated Depreciation & Depletion 24.92M 22.68M 20.29M
Property, Plant & Equipment, Net 9.16M 6.73M 8.28M
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 489.00K 149.01K 197.05K
Total Non-Current Assets 9.65M 6.88M 8.48M
Liabilities & Shareholder Equity
Total Assets 333.22M 151.90M 13.07M
Accounts Payable 7.13M 1.80M 852.59K
Short Term Debt 0.00 48.62K 4.44M
Other Current Liabilities 0.00 5.30M 0.00
Total Current Liabilities 32.48M 13.13M 28.16M
Long Term Debt 0.00 0.00 438.81K
Deferred Income Taxes 0.00 0.00 0.00
Other Non-Current Liabilities 2.28M 2.23M 3.29M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 2.28M 2.23M 84.55M
Total Liabilities 34.75M 15.36M 112.71M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 298.47M 136.54M -99.64M
Common Par 33.00K 24.34K 545.00
Additional Paid In Capital 721.72M 465.25M 177.58M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -422.55M -328.80M -277.22M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -737.00K 70.39K 0.00
Total Capitalization 298.47M 136.54M -99.20M
Total Equity 298.47M 136.54M -99.64M
Total Liabilities & Stock Equity 333.22M 151.90M 13.07M
Total Common Shares Outstanding 32.90M 23.80M 23.68M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 31.57M 12.83M 14.19M
Diluted Weighted Shares Outstanding 31.57M 12.83M 14.19M
Number of Employees 193 137 NA
Number of Part-Time Employees 0 0 NA
PTCT News

PTCT PTC Therapeutics Inc

Analysts Ratings for PTCT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 1 0
Hold 2 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PTCT ANALYST REPORT

Brokerage Partners

PTCT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs